Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Vávrová, , Ludmila,
DOB: 08-AUG-1940 (Age: 85)
Gender: female
Address:
Šárovo Kolo 116
29471 Bakov nad Jizerou (Czechia)
ID: 1992-540676-1 (ECI)
Report
Date: 22-NOV-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Psychiatrická nemocnice Kosmonosy
293 06 Kosmonosy (Czechia)
Specimen
Collected: 22-NOV-2023

Chemistry

Test 22-NOV-2023 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 296.1 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 129.2 10 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 217.1 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 53.2 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significantly elevated total cholesterol and LDL cholesterol, both of which increase cardiovascular risk, while HDL and triglycerides are within normal limits. Recommend clinical evaluation for cardiovascular risk factors and consideration of lipid-lowering therapy as appropriate.